<SEC-DOCUMENT>0001104659-24-100052-index.html : 20240916 <SEC-HEADER>0001104659-24-100052.hdr.sgml : 20240916 <ACCEPTANCE-DATETIME>20240916102256 ACCESSION NUMBER: 0001104659-24-100052 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20240916 DATE AS OF CHANGE: 20240916 GROUP MEMBERS: HEIGHTS CAPITAL MANAGEMENT, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BriaCell Therapeutics Corp. CENTRAL INDEX KEY: 0001610820 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-92289 FILM NUMBER: 241299896 BUSINESS ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 BUSINESS PHONE: (604) 921-1810 MAIL ADDRESS: STREET 1: 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR CITY: WEST VANCOUVER STATE: A1 ZIP: V7T 2X1 FORMER COMPANY: FORMER CONFORMED NAME: Ansell Capital Corp. DATE OF NAME CHANGE: 20140613 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CVI Investments, Inc. CENTRAL INDEX KEY: 0001649553 ORGANIZATION NAME: IRS NUMBER: 981253664 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 345-949-8080 MAIL ADDRESS: STREET 1: P.O. BOX 309 STREET 2: UGLAND HOUSE CITY: GRAND CAYMAN STATE: E9 ZIP: KY1-1104 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>tm2424070d1_sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: tm2424070d1_sc13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.I <SEQUENCE>2 <FILENAME>tm2424070d1_ex99-i.htm <DESCRIPTION>EXHIBIT I <TEXT> Document 2 - file: tm2424070d1_ex99-i.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.II <SEQUENCE>3 <FILENAME>tm2424070d1_ex99-ii.htm <DESCRIPTION>EXHIBIT II <TEXT> Document 3 - file: tm2424070d1_ex99-ii.htm
</DOCUMENT> </SEC-DOCUMENT>